| Document Date: 2014-02-10 19:31:08
Open Document File Size: 225,15 KBShare Result on Facebook
City Irvine / / Company Pearson / Allergan Inc. / / Country United States / Ireland / / IndustryTerm chemical name / / MedicalCondition glaucoma / multiple abnormalities / non-infectious uveitis / macular edema / central retinal vein occlusion / fetal resorptions / cataracts / secondary ocular infections / Hypersensitivity OZURDEX / retinal detachment / Carcinogenesis / Retinal Vein Occlusion OZURDEX / endophthalmitis / herpes / posterior subcapsular cataract / active epithelial herpes simplex keratitis / posterior subcapsular cataracts / Ocular hypertension Cataract Vitreous detachment Headache / dendritic keratitis / viral diseases / branch retinal vein occlusion / eye inflammation / periocular infections / cleft palate / inflammatory cytokines / Advanced glaucoma / Eye pain / Periocular Infections OZURDEX / Posterior Segment Uveitis / Advanced Glaucoma OZURDEX / Retinal Vein Occlusion / ocular herpes / Hypersensitivity / retinal detachments / inflammatory cells / Posterior Segment Uveitis OZURDEX / vaccinia / inflammation / corneal edema / varicella / mycobacterial infections / fungal diseases / secondary ocular infection / / MedicalTreatment drug delivery system / / Organization DOSAGE AND ADMINISTRATION / FDA / / / Position optic nerve head / General / / Product Intravitreal Injection / dexamethasone / WARNINGS AND PRECAUTIONS Intravitreal injections / dexamethasone sodium phosphate / Intravitreal Injection-related Effects Intravitreal injections / Posterior Lens Capsule / / ProvinceOrState California / / Technology Pharmacokinetics / drug delivery system / / URL www.fda.gov/medwatch / www.allergan.com/products/patent_notices / /
SocialTag |
OZURDEX® Prescribing Information